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Brief Communications
11-Hydroxysteroid Dehydrogenase Type 1 Deficiency
Prevents Memory Deficits with Aging by Switching
from Glucocorticoid Receptor to Mineralocorticoid
Receptor-Mediated Cognitive Control
Joyce L. W. Yau,1,2 June Noble,2 and Jonathan R. Seckl1,2
1Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, and 2Endocrinology Unit, Centre for Cardiovascular Science, The
Queen’s Medical Research Institute, Edinburgh EH16 4TJ, United Kingdom
Local brain amplification of glucocorticoids (GCs) by 11-hydroxysteroid dehydrogenase type 1 (11-HSD1) plays a pivotal role in
age-related memory deficits. 11-HSD1 deficient mice are protected from spatial memory impairments with aging, but the underlying
mechanisms are unknown. To determine which brain receptors [high-affinity mineralocorticoid receptors (MRs) or low-affinity gluco-
corticoid receptors (GRs)] are involved, spatial memory was measured in aged 11-HSD1/mice before and during intracerebroven-
tricular infusion (10 d) of spironolactone (MR antagonist) or RU486 (GR antagonist). Aged C57BL/6J control mice showed impaired
spatial memory in the Y-maze; this improved with GR blockade, while MR blockade had no effect. In contrast, aged 11-HSD1/mice
showed intact spatial memory that became impaired with MR blockade, but not GR blockade. Hippocampal MR and GRmRNA expres-
sion and plasma corticosterone levels were not significantly alteredwith spironolactone or RU486 in either genotype. These data support
the notion that 11-HSD1 deficiency in agingmice leads to lower intracellular GC concentrations in brain, particularly in the hippocam-
pus, which activate predominantly MRs to enhance memory, while in aging C57BL/6J controls, the increased intracellular GCs saturate
MRs and activate predominantly GRs, thus impairing memory, an effect reversed by GR blockade.
Introduction
Chronic glucocorticoid (GC) hypersecretion associates with age-
related cognitive decline in rodents and humans (Meaney et al.,
1995; Yau et al., 1995; Lupien et al., 1998). 11-Hydroxysteroid
dehydrogenase type 1 (11-HSD1) catalyzes intracellular regen-
eration of active GCs [corticosterone (CORT), cortisol] from
inert 11-keto forms (11-dehydrocorticosterone, cortisone), thus
locally amplifyingGCaction (Holmes and Seckl, 2006). The adult
brain expresses 11-HSD1 particularly in the hippocampus, a
region important for memory and feedback regulation of the
hypothalamic–pituitary–adrenal (HPA) axis (Jacobson and Sa-
polsky, 1991). Mice deficient in 11-HSD1 throughout life are
protected from hippocampus-dependent spatial learning and
memory impairments associatedwith agingwithout reduction in
the elevated circulating CORT levels seen with age (Yau et al.,
2001, 2007). The improved cognitive phenotype of aged 11-
HSD1 deficient mice likely occurs via lower intracellular CORT
levels (Yau et al., 2001, 2007). However, GC-related mechanisms
of cognitive effects down-stream of 11-HSD1 are unclear, and
the enzyme also catalyzes the conversion of 7-keto-cholesterol to
7-hydroxycholesterol, which may be pertinent to cognition
(Odermatt and Nashev, 2010).
GCs exert their effects on cognition via two subtypes of intra-
cellular corticosteroid receptor: high-affinity mineralocorticoid
receptors (MRs), which are almost saturated at basal levels of
CORT, and lower-affinity glucocorticoid receptors (GRs), which
become activated by high levels of CORT. The differential bind-
ing affinity of MR and GR allows the brain to cope with large
fluctuations in circulating CORT levels and plausibly underlies
the inverted U-shaped relationship between CORT levels and
hippocampal electrophysiological and cognitive functions (Reul
and de Kloet, 1985; Diamond et al., 1992), with lower CORT
levels activating procognitive actions via MR, while chronically
high “stress” levels of CORT saturate GR and impair perfor-
mance in spatial memory tasks (Kim and Diamond, 2002; Avital
et al., 2006). Moreover, MR is initially important for appraisal
processes and choice of the appropriate behavioral response to
deal with a challenge, while GR is important for storage of the
experience in the memory to prepare for future challenges, be-
havioral adaptation, and recovery (de Kloet et al., 1999). While
MRs and GRs assume opposite roles in regulating synaptic plas-
ticity, particularly under stressful conditions in young animals
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(Avital et al., 2006), the correlation between high circulating
CORT levels and impaired spatialmemory in aged rats (Issa et al.,
1990; Yau et al., 1995) implicates GR activation in age-related
cognitive decline. However, neither receptor has been consis-
tently associated directly with cognitive decline with aging, at
either a genetic or a functional level (Lund et al., 2004; Kuningas
et al., 2007; Soontornniyomkij et al., 2010).
Here, we explored the hypothesis that 11-HSD1 deficiency,
by maintaining lower intracellular GC levels in aged 11-
HSD1/mouse brain, minimizes occupancy of GR appreciably
while optimally activating memory-supporting actions via MR,
whereas in aged C57BL/6J controls, elevated GC levels acting via
chronically increased GR activation underpin cognitive deficits.
Materials andMethods
Animals. Male mice homozygous for targeted disruption of the 11-
HSD1 gene (Kotelevtsev et al., 1997) and congenic on the C57BL/6J
genetic background (Carter et al., 2009) and control C57BL/6Jmice were
bred and maintained within our biomedical research facility housed un-
der standard conditions on a 12 h light/dark cycle (lights on at 07:00
A.M.), with food and water ad libitum until experimentation at either 6
months old (young) or 24 months old (aged). All procedures were per-
formed in strict accordance with the U.K. Animals (Scientific Proce-
dures) Act, 1986.
Spatial memory testing. Aged mice were tested in the Y-maze for
hippocampal-dependent spatial recognitionmemory as described previ-
ously (Yau et al., 2007). In the training trial, each mouse was allowed to
explore themaze for 5minwith one arm closed (novel arm) and returned
to their home cage until the retrieval trial, during which they could
explore freely all three arms of the maze for 2 min. The time spent in the
novel armwas calculated as a percentage of the total time in all three arms
(Dellu et al., 1992; Conrad et al., 1999). A 1 min intertrial interval (ITI)
was first used to confirm spontaneous novelty exploration and test vi-
sion.Micewere retested 4 d later with a 2 h ITI tomeasure baseline spatial
memory performance. For each Y-maze test, the spatial cues around the
maze were changed. MR or GR antagonist (or vehicle control) treatment
was started 1 week after behavioral testing and all mice were retested in
the Y-maze with a 2 h ITI during the 10th day of osmotic mini-pump
infusion. Morning tail venesection blood samples were taken (8:30–9:30
A.M.) the day after the final Y-maze test for CORTmeasurements. Mice
were culled by cervical dislocation the following morning, and brains
were removed, snap frozen on soft dry ice, and stored at80°C. Correct
placement of cannula was confirmed histologically.
Surgery and drug treatment. Aged (24-month-old) mice (11-
HSD1/ and C57BL/6J controls) were randomly assigned to intracere-
broventricular GR antagonist, MR antagonist, or vehicle. Mice were
anesthetized with halothane (3% for induction, 1.5–2% for mainte-
nance) and mounted in a stereotaxic apparatus (David Kopf Instru-
ments). Buprenorphine (0.05 mg/kg) was given subcutaneously before a
midline skin incision in the cranial region. A 30
gauge brain infusion cannula (Alzet) was im-
planted into the lateral ventricle [coordinates
relative to bregma: anteroposterior 1.2 mm;
lateral0.8 mm (midline); dorsoventral2.5
mm from skull surface (Paxinos and Franklin,
2003)] and secured to the skull with cyanoac-
rylate. The cannula was connected by vinyl
catheter tubing to the flow moderator of the
Alzet osmotic mini-pumps (model 1002) filled
with either the GR antagonist RU486 (mifepri-
stone) (100 ng/h) or the MR antagonist spi-
ronolactone (100 ng/h) or vehicle (30%
propylene glycol in artificial CSF, 0.25 l/h)
and implanted subcutaneously. Antagonist
(Sigma) doses were according to published
studies (van Haarst et al., 1996; Oitzl et al.,
1998b; Yau et al., 1999).
In situ hybridization histochemistry. Brain sec-
tions (10m) at the levels of the anterior hippocampus and paraventricular
nucleus were postfixed and hybridized with [35S]-UTP-labeled cRNA anti-
sense probes transcribed in vitro from cDNA clones encoding rat MR and
GR and quantified at the microscopic level as previously described (Yau et
al., 1997).
Corticosterone assay. Plasma CORT levels were measured using an in-
house radioimmunoassay (RIA) (Al-Dujaili et al., 1981)modified formicro-
titer plate scintillation proximity assay (GE Healthcare). For brain CORT
levels, steroids were extracted by solvolysis from the dissected tissues as de-
scribed previously (Ebner et al., 2006) with modifications. Tissue homoge-
nates in phosphate buffer were added slowly to 95% ethanol at 30°C to
avoidproteindenaturation and steroid trapping.After incubation for 16hat
30°C, extracts were centrifuged, dried, reconstituted in 40% methanol,
and extracted using C18 Sep-Pak cartridges before RIA.
Statistical analysis. Data are expressed as mean SEM and were ana-
lyzed using either a one-way or two-way ANOVA followed by Scheffe´ F
tests post hoc as appropriate for individual between-group comparisons.
The percentage time in the novel arm was compared with the other arms
of the Y-maze by Student’s paired t test, as were before and after treat-
ment times in the novel arm. Significance was set at p 0.05.
Results
Effect of aging and 11-HSD1 deficiency on plasma and brain
corticosterone levels
Basal plasmaCORT levels increasedwith age inboth11-HSD1/
and C57BL/6J control mice (F(1,28) 6.3, p 0.05) (Fig. 1A), con-
sistentwithprevious reports in rodents andhumans (Issa et al., 1990;
Yau et al., 1995; Lupien et al., 1998), but there was no effect of geno-
type. CORT concentrations in the hippocampus, which reflect free
CORT from the periphery and intracellular CORT from11-HSD1
activity, increased with age in C57BL/6J mice (F(1,28)  5.7, p 
0.005) but not in 11-HSD1/ mice (Fig. 1B). Two-factor
ANOVArevealed an effect of genotype (F(1,28) 12.2,p 0.01) and
age  genotype interaction (F(1,28)  5.8, p  0.05). Aged 11-
HSD1/ hippocampal CORT levels were significantly decreased
(by 57%, p  0.01) compared to aged controls. This reduction in
hippocampal CORTwas not evident in young 11-HSD1/mice
(Fig. 1B). In the cortex,while 11-HSD1deficiency hadno effect on
CORT in young mice, levels in aged 11-HSD1/mice were de-
creased by 44% (F(1,28) 6.3, p 0.05) compared to aged controls
(Fig. 1C).
Spatial memory of aged 11-HSD1/ and C57BL/6J mice
before treatment
Baseline spatial memory performances of all aged (24-month-
old) C57BL/6J and 11-HSD1/mice were measured before
randomization to treatment (vehicle, RU486, spironolac-
Figure 1. Corticosterone levels in plasma and brain of young (6-month-old) and aged (24-month-old) 11-HSD1/ and
C57BL/6Jmice.A, Age increased plasma CORT levels in both 11-HSD1/ and C57BL/6Jmicewith no effect of genotype.B, Age
increasedhippocampal CORT levels in C57BL/6Jmicebutnot 11-HSD1/mice.Hippocampal CORT levelswere reduced in aged
11-HSD1/ mice. C, Age did not significantly increase cortex CORT levels, but 11-HSD1 deficiency decreased cortex CORT
levels in the aged mice. Filled bars, C57BL/6J mice (n 6 and 10 for young and aged, respectively); open bars, 11-HSD1/
mice (n 7 and 9 for young and aged, respectively). All values are means SEM. *p 0.05; **p 0.01.
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tone). Both genotypes performed the immediate version (1
min ITI) of the Y-maze, showing similar neophilia, spending
significantly more time in the novel arm than previously vis-
ited arms ( p 0.01) (Figs. 2A, 3A). However, aged C57BL/6J
mice failed to recognize the novel arm following a 2 h ITI (Fig.
2A), while aged 11-HSD1/mice maintained spatial mem-
ory, spending significantly more time in the novel arm than
previously visited arms ( p  0.001) (Fig. 3A) and than the
novel arm in aged C57BL/6J controls (F(1,44)  14.3, p 
0.001) (Fig. 2A).
Improved spatial memory in aged C57BL/6J mice following
central GR blockade
The intracerebroventricular infusion of vehicle had no effect on
the impaired spatial memory of aged C57BL/6J mice before the
drug, showing the lack of any practice effect (novel arm before
and after vehicle, paired t test, p 0.15), and spironolactone did
not affect the already impaired performance, although there was
a trend for the mice to spend even less time in the novel arm than
before the drug (paired t test, p  0.10) (Fig. 2B). In contrast,
RU486 improved spatial memory, with themice spending signif-
icantly more time in the novel arm ( p 0.05) than in the previ-
ously visited arms and than in individual performances before
RU486 ( p 0.05) (Fig. 2B).
Impaired spatial memory in aged 11-HSD1/mice
following central MR blockade
The maintained spatial memory of aged 11-HSD1/ mice in
the Y-maze (2 h ITI) before the drug was not altered by intrace-
rebroventricular infusion of vehicle (Fig. 3B). In contrast to aged
C57BL/6J controls, RU486 had no impact on spatial memory in
aged 11-HSD1/ mice with maintained recognition of the
novel arm ( p 0.05 compared to other arms) (Fig. 3B). Spatial
memory in aged 11-HSD1/mice was, however, impaired by
intracerebroventricular spironolactone, with mice failing to rec-
ognize the novel arm and spending significantly less time there
than before treatment ( p 0.05) (Fig. 3B).
Hippocampal corticosteroid receptor expression and plasma
corticosterone levels
An alternative explanation for these findings is that 11-HSD1
deficiency and/or receptor antagonist administration alters ex-
pression of GR and/or MR or plasma CORT levels. However,
there was no significant effect of treatment (spironolactone or
RU486) on MR or GR mRNA levels in any hippocampal subre-
gion (Fig. 4A,B) or on GRmRNA in the paraventricular nucleus
(PVN) of the hypothalamus (Fig. 4C). Basal plasma CORT levels
inC57BL/6J and 11-HSD1/mice, respectively, following spi-
ronolactone (122 11 nM; 143 28 nM) orRU486 (116 13 nM;
164  10 nM) treatments were not significantly different from
vehicle controls (107 14 nM; 143 21 nM), although there was
Figure 2. The impaired spatial memory of aged C57BL/6J mice was reversed with cen-
tral GR but not MR blockade. A, Before antagonist treatment, aged C57BL/6J mice (n
19) spent more time in the novel arm of the Y-maze than other arms following a 1 min ITI,
but with a 2 h ITI, they failed to distinguish the novel arm showing impaired spatial
memory. B, The impaired spatial memory of aged C57BL/6J mice (n 7– 8/group) before
the drug was reversed after 10 d intracerebroventricular RU486, with mice now spending
more time in the novel arm than other arms. All values are means SEM. *p 0.05.
Figure 3. The intact spatial memory of aged 11-HSD1/ mice became impaired
with central MR but not GR blockade. A, Before antagonist treatment, aged 11-
HSD1/ mice (n 24) spent more time in the novel arm than other arms of Y-maze
after both the 1 min and 2 h ITI, thus showing intact spatial memory. B, This intact spatial
memory of the aged 11-HSD1/ mice (n  7– 8/group) before the drug became
impaired after 10 d intracerebroventricular spironolactone but not with vehicle or RU486.
All values are means SEM. *p 0.05.
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an effect of genotype (F(1,39) 5.28, p 0.05), with significantly
higher CORT levels in 11-HSD1/mice treated with RU486.
Discussion
The present results show that spatial memory deficits in aged
mice are ameliorated by central GR antagonism. In contrast,
maintained spatial memory in aged 11-HSD1/ mice is re-
versed by central MR blockade. These data (1) suggest that (i)
age-related memory deficits are associated with long-term brain
GC excess acting via GR; (ii) such deficits are not due to irrevers-
iblemolecular and structural changes in the aged brain, at least in
mice; (iii) intracellular CORT levels appear crucial; and (iv) 11-
HSD1 deficiency, by keeping intracerebral CORT levels low with
aging, allows spatial-memory-enhancingMR-mediated effects to
predominate; and (2) afford clear evidence that GR and MR un-
derpin distinct effects on cognition with aging.
The relationships betweenGCs, their receptors, and cognition
are complex. In general, acute elevations of GCs tend to facilitate
learning, notably in a fearful context, but impair retrieval
(Roozendaal et al., 2006; Abrari et al., 2009) (Roozendaal, 2002).
Chronic GC excess impairs hippocampal-dependent spatial/de-
clarative memory formation (Lupien et al., 1997; Conrad, 2010).
Here, the cognition-enhancing effect of GR antagonism in aged
C57BL/6Jmice wasmarked. Indeed, chronic RU486 frommiddle
age abolishes electrophysiological disturbances found in aged
control mouse hippocampal slices (Talmi et al., 1996). However,
chronic stress-induced morphological remodeling of prefrontal
pyramidal neurons was not reversed with recovery from stress in
aged rats (Bloss et al., 2010), suggesting that not all deleterious
long-term effects of GCs are reversible in the aged animal. In
contrast, in young rats, GR antagonism only modestly facilitates
spatial learning in the “stressful” water maze when circulating
CORT levels are elevated (Oitzl et al., 1998a,b), perhaps because
young rats have lower CORT levels that barely occupy GR and/or
havemore robust cognition. The lack of effect of GR blockade on
spatial memory in aged 11-HSD1/ mice suggests that their
lower brainCORT levels were insufficient to substantially occupy
GR (Ratka et al., 1989). In contrast, MR antagonism impaired
spatial memory in aged 11-HSD1/mice, consistent with the
importance of MR occupancy in processing of hippocampus-
dependent memory (Oitzl and de Kloet, 1992; Conrad et al.,
1997; Douma et al., 1998; Yau et al., 1999). Thus the balance of
activatedMR andGR, which are critical for neuronal excitability,
stress responsiveness, and behavioral adaptation (De Kloet et al.,
1998), appears shifted from predominantly GR effects in aged
controls to predominantly MR actions in aged 11-HSD1/
mice. Many hippocampal GC-responsive genes are regulated ei-
ther byMRorGR,with fewer genes responsive to both (Datson et
al., 2001), supporting the notion that distinct pathways underpin
the effects of the antagonists seen here.
11-HSD1 deficiency did not affect the expression of hip-
pocampal MR and GR or PVN GR mRNAs in aged mice despite
the decreased intracerebral CORT levels. This contrasts with in-
creased GR mRNA in hippocampus and PVN of young 11-
HSD1/ mice on the same strain background (Carter et al.,
2009), which plausibly compensates for the lack of intracellular
CORT regeneration by increasing cellular responsiveness. This
mechanism appears lost in aged animals. The parallel rise in
blood CORT levels in both genotypes with aging indicates that
such implied reduced plasticity of GR, which occurs in normally
aging rodents (Eldridge et al., 1989a,b), might contribute to the
GC excess with aging. Moreover, in the agedmice of either geno-
type, continuous antagonism of brain MR or GR did not alter
CORT levels. While acute blockade of brain MR increases basal
circulating CORT levels in rats (Ratka et al., 1989; van Haarst et
al., 1997), chronic blockade of brain MR had no effect on basal
plasma CORT levels in young rats (Yau et al., 1999), as in our
aged mice, suggesting that adaptations in the HPA axis have oc-
curred. In contrast, acute blockade of brainGRhas been shown to
increase (vanHaarst et al., 1997) or have no effect on (Ratka et al.,
1989) plasma CORT levels, while chronic blockade of brain GR
had no effect on basal morning plasma CORT levels (van Haarst
et al., 1996), consistent with our present observation, but in-
creased circadian peak levels of CORT (van Haarst et al., 1996).
Although plasma CORT levels showed a trend to be higher in
aged 11-HSD1/ mice than in aged C57BL/6J controls, this
was only significant in the RU486-treated animals. However, the
effects of intracerebroventricular RU486 in the aged 11-
HSD1/ mice were not a consequence of the higher plasma
CORT per se, since spatial memory was unaffected compared to
before treatment.
These findings suggest that decreasing GR activation/increas-
ing MR activation, either by reducing brain GC levels with a
selective 11-HSD1 inhibitor or by GR antagonism,may amelio-
rate memory impairments even in already aged individuals. The
Figure 4. Brain MR and GR mRNA expression in aged 11-HSD1/ and C57BL/6J mice
following central MR and GR blockade. A–C, Expression of hippocampal MR (A) and GR (B) and
PVN GR (C) mRNA was unaffected by 11-HSD1 deficiency and 10 d intracerebroventricular
RU486 or spironolactone. All values are means SEM.
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long-term use of GR antagonists in humans may be problematic,
since chronic administration of RU486 (mifepristone) produces
generalized GC resistance with high levels of cortisol in compen-
sation (Bamberger and Chrousos, 1995). Perhaps intermittent
therapy might exert net cognitive benefits. The use of selective
11-HSD1 inhibitors to reduce the levels of GC in the aged brain,
to reverse the balance of receptor activation from predominantly
GR to predominantly MR, appears promising. Indeed, an 11-
HSD inhibitor improved aspects of cognitive function in elderly
men and patients with type 2 diabetes without increasing HPA
activity (Sandeep et al., 2004). Moreover, short-term treatment
of already aged control mice with a CNS-active selective 11-
HSD1 inhibitor improves spatial memory over days (Sooy et al.,
2010).
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